Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China · Delayed Price · Currency is CNY 11.01
+0.31 (2.90%)
Oct 23, 2026, 3:00 PM CST
SHA:688553 Revenue
Sichuan Huiyu Pharmaceutical had revenue of 282.65M CNY in the quarter ending June 30, 2026, with 32.04% growth. This brings the company's total for the last twelve months to 1.10B, up 8.04% year-over-year. In the year 2025, Sichuan Huiyu Pharmaceutical had annual revenue of 998.14M, down -8.79%. That makes Sichuan Huiyu Pharmaceutical the 18,917th largest company in the world by revenue and 3,447th in China.
Revenue (ttm)
1.10B
Revenue Growth
+8.04%
P/S Ratio
6.08
Revenue / Employee
758.56K
Employees
1,446
Market Cap
6.87B
Revenue by Geography
- China 782.05M 78.4%
- Overseas 216.09M 21.6%
Fiscal year ended Dec 31, 2025 See the full SHA:688553 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 998.14M | -96.24M | -8.79% |
| Dec 31, 2024 | 1.09B | 167.31M | 18.05% |
| Dec 31, 2023 | 927.08M | -566.19M | -37.92% |
| Dec 31, 2022 | 1.49B | -330.47M | -18.12% |
| Dec 31, 2021 | 1.82B | 459.54M | 33.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.58B |
| Northeast Pharmaceutical Group | 6.56B |
| KPC Pharmaceuticals,Inc. | 4.87B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Zhejiang Tianyu Pharmaceutical | 3.30B |
| Sunflower Pharmaceutical Group | 2.51B |
| Guilin Sanjin Pharmaceutical | 2.02B |
| Zhejiang Garden Biopharmaceutical | 1.27B |